Factsheet
This factsheet provides an overview of international development assistance (consisting of official development assistance (ODA) and philanthropic giving) related to pneumonia including projects focused on prevention and treatment.
Key findings from this analysis show that:
- International development assistance to pneumonia has halved since a peak of US$1 billion in 2015.
- Both ODA and philanthropic giving to combat pneumonia have fallen in recent years.
- More than half of all international development assistance to pneumonia was disbursed to countries in sub-Saharan Africa.
- High-burden countries are generally well targeted by pneumonia international development assistance.
- International development assistance for pneumonia has remained much smaller than for HIV/Aids and malaria.
- Research and development accounts for the largest share of non-vaccine pneumonia assistance.
The data available covers 2007−2018 and is broken down to show trends in funding across this period by region, by country, in comparison with other selected health subsectors and non-vaccine funding.
